Quote:

---

faraifarai Monday, 05/15/17 11:38:44 AM
Re: cybermich post# 182070
Post # of 182113

I'm not sure how we don't get positive Brilacidin IBD and OM results. All one has to do as look at their interim results already posted through 2 of 3 cohorts for the IBD, and for half the patients for OM. Trend lines and data doesn't tank on a third cohort with 6 patients, or the remaining OM patients. That would be unheard of if you analyze their current results:

Brilacidin for IBD Interim Data:
http://www.cellceutix.com/press-release/2017/...ve-colitis



Brilacidin for Oral Mucositis Interim Data
http://www.cellceutix.com/press-release/2017/...-treatment



Prurisol, the 200 mg arm did better than Otezla in the Phase 2 trial---


I wish they would bring back those airplanes with the advertising banners on the rear, or some smoke signals, or any other more obvious signals that these drugs are working in actual trials with actual humans and safely.

Doesn't take a genius to see where this is headed. Just have to read the data releases.

Easy to argue on pointless points, hard to argue on firm data.

---